The epidemiological dimension of TB/HIV co-infection

Santos, Maria de Lourdes Sperli Geraldes; Ponce, Maria Amélia Zanon; Vendramini, Silvia Helena Figueiredo; Villa, Tereza Cristina Scatena; Santos, Natália Sperli Geraldes Marin dos; Wysocki, Anneliese Domingues; Kuyumijian, Fátima Grisi; Gazetta, Cláudia Eli

doi:10.1590/s0104-11692009000500014

Cited by 22 publications

(30 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Six reports each were from the USA (226,904)[11], [17]–[19], [22], [54] and Brazil (4,841) [29], [37], [42], [46], [49], [56], five were from Nigeria (2,520) [21], [32], [47], [52], [55], four each were from Ethiopia (2,609) [28], [34], [36], [44] and Spain (10,809) [14], [24], [26], [40], three were from India (1,825) [27], [45], [59], two each were from Iran (721) [43], [53], South Africa (374) [23], [50], Zambia (2,309) [16], [35], and Zimbabwe (2,049) [15], [58], and one each was from Cambodia (441) [25], Trinidad and Tobago (121) [41], Israel (1,059) [51], Netherland (13,269) [30], Singapore (184) [48], Tanzania (233) [39], Thailand(54) [31], Togo(569) [57], UK(157) [20], Ukraine(968) [33], and Vietnam(450) [38]. Twenty-nine reports screened HIV infection among TB patients (n = 22,884)[15]–[17], [19]–[23], [26]–[28], [31], [33]–[36], [38], [41], [42], …”

Section: Resultsmentioning

confidence: 99%

Prevalence of TB/HIV Co-Infection in Countries Except China: A Systematic Review and Meta-Analysis

Gao

Zheng

2013

PLoS ONE

View full text Add to dashboard Cite

BackgroundTB and HIV co-epidemic is a major public health problem in many parts of the world. But the prevalence of TB/HIV co-infection was diversified among countries. Exploring the reasons of the diversity of TB/HIV co-infection is important for public policy, planning and development of collaborative TB/HIV activities. We aimed to summarize the prevalence of TB and HIV co-infection worldwide, using meta-analysis based on systematic review of published articles.MethodsWe searched PubMed, Embase, and Web of Science for studies of the prevalence of TB/HIV co-infection. We also searched bibliographic indices, scanned reference lists, and corresponded with authors. We summarized the estimates using meta-analysis and explored potential sources of heterogeneity in the estimates by metaregression analysis.ResultsWe identified 47 eligible studies with a total population of 272,466. Estimates of TB/HIV co-infection prevalence ranged from 2.93% to 72.34%; the random effects pooled prevalence of TB/HIV co-infection was 23.51% (95% CI 20.91–26.11). We noted substantial heterogeneity (Cochran’s χ 2 = 10945.31, p<0.0001; I 2 = 99.58%, 95% CI 99.55–99.61). Prevalence of TB/HIV co-infection was 31.25%(95%CI 19.30–43.17) in African countries, 17.21%(95%CI 9.97–24.46) in Asian countries, 20.11%(95%CI 13.82–26.39) in European countries, 25.06%(95%CI 19.28–30.84) in Latin America countries and 14.84%(95%CI 10.44–19.24) in the USA. Prevalence of TB/HIV co-infection was higher in studies in which TB diagnosed by chest radiography and HIV diagnosis based on blood analyses than in those which used other diagnostic methods, and in countries with higher prevalence HIV in the general population than in countries with lower general prevalence.ConclusionsOur analyses suggest that it is necessary to attach importance to HIV/TB co-infection, especially screening of TB/HIV co-infection using methods with high sensitivity, specificity and predictive values in the countries with high HIV/AIDS prevalence in the general population.

show abstract

Section: Resultsmentioning

confidence: 99%

Prevalence of TB/HIV Co-Infection in Countries Except China: A Systematic Review and Meta-Analysis

Gao

Zheng

2013

PLoS ONE

View full text Add to dashboard Cite

show abstract

“…15,17,18 Poor recording of supervision of the medication dose among the patients studied could indicate a barrier in the fl ow of communication between health care levels, which usually hinders the continuity if a co-infected patient is required to be transferred from their followup location. 24 The percentage of cure was relatively low, which could imply that it was diffi cult to treat co-infected patients, who may show more severe forms of TB.…”

Section: Discussionmentioning

confidence: 99%

Áreas de vulnerabilidade para co-infecção HIV-aids/TB em Ribeirão Preto, SP

et al. 2011

Self Cite

View full text Add to dashboard Cite

show abstract

“…Diseases such as TB and HIV are historically s gmazed and the nega ve impact generates dras c consequences in terms of treatment dropouts and elevated mortality rates (19) .…”

Section: Discussionmentioning

confidence: 99%

Avaliação do acesso ao tratamento de tuberculose por coinfectados ou não pelo vírus da imunodeficiência humana

Rodrigues

Scatena

Vendramini

et al. 2012

Rev. esc. enferm. USP

Self Cite

View full text Add to dashboard Cite

Este estudo objetivou avaliar o acesso ao tratamento das pessoas com tuberculose tanto coinfectadas ou não pelo Vírus da Imunodeficiência Humana (HIV). Trata-se de estudo transversal - com utilização do instrumento Primary Care Assessment Tool aplicado a 95 pessoas - que abordou questões sobre o acesso ao tratamento em município do interior paulista. Para avaliação do acesso ao tratamento, utilizou-se o teste t de Student. Os escores médios das variáveis foram analisados individualmente e comparados entre os dois grupos (pessoas com TB e coinfectadas com HIV e pessoas com TB não coinfectadas pelo HIV). Os escores médios mostraram que as coinfectadas pelo HIV apresentaram maiores dificuldades na obtenção do acesso do que as não coinfectadas. Os profissionais visitavam mais vezes as coinfectadas quando comparadas às não coinfectadas; as coinfectadas quase nunca realizavam o tratamento da doença em posto de saúde perto de sua residência. Há, portanto, necessidade de maior integração e comunicação entre os Programas de Tuberculose e DST/aids.

show abstract

The epidemiological dimension of TB/HIV co-infection

Abstract: This study aimed to analyze the epidemiological indicators of TB/HIV co-infection in

Cited by 22 publications

References 9 publications

Prevalence of TB/HIV Co-Infection in Countries Except China: A Systematic Review and Meta-Analysis

Prevalence of TB/HIV Co-Infection in Countries Except China: A Systematic Review and Meta-Analysis

Áreas de vulnerabilidade para co-infecção HIV-aids/TB em Ribeirão Preto, SP

Avaliação do acesso ao tratamento de tuberculose por coinfectados ou não pelo vírus da imunodeficiência humana

Contact Info

Product

Resources

About